Smoking cessation is followed by a sharp but transient rise in the incidence of overt autoimmune hypothyroidism - A population-based case-control study
Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Standard
Smoking cessation is followed by a sharp but transient rise in the incidence of overt autoimmune hypothyroidism - A population-based case-control study. / Carlé, Allan; Pedersen, Inge Bülow; Knudsen, Nils; Perrild, Hans; Ovesen, Lars; Rasmussen, Lone Banke; Jørgensen, Torben; Laurberg, Peter.
I: Clinical Endocrinology, Bind 77, Nr. 5, 2012, s. 764–772.Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - JOUR
T1 - Smoking cessation is followed by a sharp but transient rise in the incidence of overt autoimmune hypothyroidism - A population-based case-control study
AU - Carlé, Allan
AU - Pedersen, Inge Bülow
AU - Knudsen, Nils
AU - Perrild, Hans
AU - Ovesen, Lars
AU - Rasmussen, Lone Banke
AU - Jørgensen, Torben
AU - Laurberg, Peter
N1 - © 2012 Blackwell Publishing Ltd.
PY - 2012
Y1 - 2012
N2 - BACKGROUND: Current smoking is associated with a low prevalence of thyroid auto-antibodies. On the other hand, smoking withdrawal enhances thyroid autoantibody level and may be a risk factor for development of hypothyroidism. Aim of the study was to assess the association between smoking habits (smoking cessation in particular) and development of autoimmune hypothyroidism. DESIGN: Populations-based case-control study. PARTICIPANTS: Cases (n=140) newly diagnosed with primary autoimmune overt hypothyroidism were identified prospectively by population monitoring (2,027,208 person-years of observation) of all thyroid function tests performed in the two well-defined geographical areas. Individually age-, sex-, and region-matched euthyroid controls (n=560) were simultaneously included from the same population. MEASUREMENTS: Participants gave details on smoking habits including smoking withdrawal and other lifestyle factors. Smoking habits were verified by measuring urinary cotinine (a nicotine metabolite). RESULTS: Incident hypothyroidism was very common in people who had recently stopped smoking: OR vs. never smokers (95%-CI); quit smoking <1 years: 7.36 (2.27-23.9); 1-2 years: 6.34 (2.59-15.3); 3-10 years: 0.75 (0.30-1.87); >10 years: 0.76 (0.38-1.51). Results were consistent in both sexes and irrespective of age. Within two years after smoking cessation, the percentage of hypothyroid cases attributable to cessation of smoking was 85%. Current smoking was not associated with altered risk for developing overt hypothyroidism (OR: 0.92 (0.57-1.48)). CONCLUSIONS: The risk of having overt autoimmune hypothyroidism diagnosed is more than 6 fold increased the first 2 years after cessation of smoking. Clearly smoking cessation is vital to prevent death and severe disease. However, awareness of hypothyroidism should be high in people who have recently quit smoking, and virtually any complaint should lead to thyroid function testing. © 2012 Blackwell Publishing Ltd.
AB - BACKGROUND: Current smoking is associated with a low prevalence of thyroid auto-antibodies. On the other hand, smoking withdrawal enhances thyroid autoantibody level and may be a risk factor for development of hypothyroidism. Aim of the study was to assess the association between smoking habits (smoking cessation in particular) and development of autoimmune hypothyroidism. DESIGN: Populations-based case-control study. PARTICIPANTS: Cases (n=140) newly diagnosed with primary autoimmune overt hypothyroidism were identified prospectively by population monitoring (2,027,208 person-years of observation) of all thyroid function tests performed in the two well-defined geographical areas. Individually age-, sex-, and region-matched euthyroid controls (n=560) were simultaneously included from the same population. MEASUREMENTS: Participants gave details on smoking habits including smoking withdrawal and other lifestyle factors. Smoking habits were verified by measuring urinary cotinine (a nicotine metabolite). RESULTS: Incident hypothyroidism was very common in people who had recently stopped smoking: OR vs. never smokers (95%-CI); quit smoking <1 years: 7.36 (2.27-23.9); 1-2 years: 6.34 (2.59-15.3); 3-10 years: 0.75 (0.30-1.87); >10 years: 0.76 (0.38-1.51). Results were consistent in both sexes and irrespective of age. Within two years after smoking cessation, the percentage of hypothyroid cases attributable to cessation of smoking was 85%. Current smoking was not associated with altered risk for developing overt hypothyroidism (OR: 0.92 (0.57-1.48)). CONCLUSIONS: The risk of having overt autoimmune hypothyroidism diagnosed is more than 6 fold increased the first 2 years after cessation of smoking. Clearly smoking cessation is vital to prevent death and severe disease. However, awareness of hypothyroidism should be high in people who have recently quit smoking, and virtually any complaint should lead to thyroid function testing. © 2012 Blackwell Publishing Ltd.
U2 - 10.1111/j.1365-2265.2012.04455.x
DO - 10.1111/j.1365-2265.2012.04455.x
M3 - Journal article
C2 - 22651374
VL - 77
SP - 764
EP - 772
JO - Clinical Endocrinology
JF - Clinical Endocrinology
SN - 0300-0664
IS - 5
ER -
ID: 40171719